Accumulating evidence has revealed that the aberrant expression of CS synthases and CS modification enzymes along with increased CSPGs in the tumor microenvironment are characteristic hallmarks of several types of cancer, including glioma [17,39,40,41,42,43,44]. The gene discussed is CS; the disease is cancer.